LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    #EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

    02/10/2020
    PRESS RELEASE

    #EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference

    As Europe looks to the implementation of the EU Green Deal and a sustainable post-COVID future, this year’s conference will highlight how industrial biotechnology and bio-based innovation can play a key role in the transition to a more sustainable and circular economy.

    Brussels, 2 October 2020 – The European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) will start on Monday in a new fully digital format, providing 5 days of insights and engagements.

    Now in its 13th edition, the conference continues to attract leading industry and policy experts to discuss opportunities and challenges for these transformative technologies. This year the Forum will have a special focus on how biotechnology innovation can help advance the Green Economy. Six main topics will be highlighted during EFIB: 1) Green. Circular. Sustainable; 2) Food, Feed & Nutrition; 3) Fashion & Textiles; 4) Financing & Investment; 5) Materials & Packaging; and 6) Bioprocesses & Technologies. “This week’s celebrations of the first fully digital Biotech Week provide an ideal lead-in to #EFIB2020, which launches on Monday. This year EFIB is also in a digital setting and we are looking forward to celebrating the sector’s latest achievements in harnessing the power of innovation to help deliver new solutions,” said Agnes Borg, Industrial Biotechnology Director at EuropaBio.

    This year’s agenda will amongst others feature Director-General of DG GROW Kerstin Jorna, Forum for the Future CEO Dr Sally Uren OBE and Susanne Pedersen, Assistant Director-General and head of Investment and Policy Solutions of the Global Green Growth Institute. Other speakers will include leading executives from companies such as DSM, Novozymes, Givaudan, Cargill, Stora Enso, and Lenzing as well as distinguished speakers from the European Commission, the European Food Safety Authority, the European Circular Bioeconomy Fund, the Laudes Foundation, and many more. The agenda will also feature perspectives on how industry can help drive the SDG agenda forward, a session looking to the future of biotechnology innovation in Europe co-organised with the European Federation of Biotechnology, and much more!

    #EFIB2020 participants will also be able to engage with innovators from start-ups and academia through the Digital Start-Up Forum and the Innovation Campus digital academic poster presentations. A winner for both the Start-Up Forum and Innovation Campus will be announced at the end of the conference week.

    For more information about EFIB2020, please visit our website.

    EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more
    03/02/2026

    Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe


    Read more
    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives


    Read more

    Important links

    • OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States
    • Ecolab Life Sciences joins EuropaBio: Helping Shape the Future of Life Sciences Manufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.